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Aim: To estimate how many asthmatic children underwent spirometry testing in one year in
a large Italian region, and evaluate sociodemographic determinants.
Methods: Data were retrieved from the administrative databases that store all pharmacolog-
ical and diagnostic prescriptions issued to individuals living in the Lombardy Region. The anal-
ysis involved prescriptions dispensed to all 6e17 year olds (1,047,241 subjects) during 2008.
Youths were identified as asthmatics by a previously validated strategy. Number of subjects
having 1 spirometry claims was calculated, and factors associated with the probability of
undergoing spirometry were evaluated by multivariate analysis.
Results: A total of 40,528 (3.9%) asthmatic subjects were identified. Only 30% of them under-
went 1 spirometry during 2008, with differences between local health units (range 22e45%)
and degree of anti-asthmatic use (26e35%). Moreover, in a multivariate analysis, the chance of
undergoing spirometry was greater in boys than in girls (ORZ 2.3).
Conclusions: A low percentage of asthmatic children, especially girls (who are more at risk of
developing severe disease in adulthood), underwent spirometry during 1-year period. This
highlights a low compliance with guidelines in the monitoring of childhood asthma. Educational
intervention is needed in order to encourage use of spirometry in primary care settings.
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The burden of childhood asthma worldwide varies, but it is
substantial everywhere.1 The prevalence of lifetime
asthma for Italian 6e7 years of age children did not change
significantly between 1995 and 2002 (from 9.1 to 9.5%),
while it increased significantly for adolescents 13e14 years
of age (from 9.1 to 10.4).2 Patients’ perceptions of airflow
obstruction are highly variable, and under-reporting of
symptoms is frequent among children. In order to obtain
objective measures of lung function and optimize asthma
control, periodic monitoring of airway function is necessary
in asthma management. Guidelines for the diagnosis and
treatment of asthma in childhood3e5 recommend the use of
spirometry every 1e2 years or more frequently, and always
at the following times: at the initial assessment; after
treatment is initiated and symptoms have stabilized; and
during periods of progressive or prolonged loss of asthma
control. It has been reported that a decreased FEV1/FVC
ratio not only suggests current obstruction, but also
represents a measure of exacerbation risk and likely
persistence of disease in adulthood.6 Although a reliable
spirometry can be performed in many children as young as 4
years of age,7,8 only in older children the risk of misdiag-
nosis of asthma is reduced and less confused with transitory
wheezing, which in the majority of the cases disappears by
school age. However, even though many transient early
wheezers no longer wheeze at age 6, they still maintain an
impaired lung function at 9e119 and at 16 years,10 and are
more likely to eventually develop chronic obstructive
pulmonary disease. Although spirometry is a key clinical
test for asthma diagnosis and management, in a cohort of
2688 American children only 23% had 1 spirometry testing
during a three year observation period11 and only 43% of
a population of Canadian children received spirometry to
establish asthma diagnosis.12 The objective of this study
was therefore to assess the extent of use of spirometry
testing in a population of children and adolescents previ-
ously identified as asthmatic by a validated strategy based
on anti-asthmatic prescriptions.13
Methods
The data sources were health administrative databases of
the Lombardy Region, and in particular: database collecting
prescriptions dispensed by the retail pharmacies of the 15
local health units (LHUs) in the Lombardy Region and
reimbursed by the Italian national health service; hospital
discharge form database; database collecting prescriptions
for diagnostic tests and specialist visits performed in
hospital outpatient ambulatories. The study period was
from January 1 to December 31, 2008. The study population
was composed of 1,047,241 children and adolescents 6e17
years old, male/female ratio 1.06, living in the Lombardy
Region. The population sample represented 15% of the
overall Italian 6e17 year old paediatric population for the
year 2008. Data were managed and analysed using an
anonymous patient code. Anti-asthmatics were classified as
drugs belonging to the R03 main therapeutic group of the
Anatomical Therapeutic Chemical classification system
(ATC). As previously described,14 subjects 6e17 years oldreceiving at least one package of anti-asthmatic drugs in
age-appropriate formulations were defined as Potential
Asthmatics (PA). This strategy for the identification of PA
patients has been validated as a good proxy of disease
prevalence (sensitivity 90%, specificity 98%).13 PA were
divided into three groups based on number of packages
received during 2008: (A) “occasional users”, subjects
receiving only one package; (B) “low users”, subjects
receiving 2e4 packages; (C) “high users”, subjects
receiving 5 or more packages. Percentage of spirometry
testing claims during 2008 was calculated in the three
different subgroups and in each of the 15 LHUs. Prevalence
data by age and gender were calculated as number of
children treated with anti-asthmatic drugs per 100 inhabi-
tants. The prevalence of asthma at LHU level was esti-
mated by dividing the number of PA by the residents of
each LHU. A chi-square test was performed to compare the
proportion of youths with spirometry testing by gender, age
group, and degree of anti-asthmatic drug utilization.
Finally, a logistic regression analysis was performed in order
to identify the determinants of spirometry testing. The
dependent variable was at least one claim for spirometry
testing during 2008. Independent variables were degree of
anti-asthmatic drug use (no use, occasional, low, high use)
and LHU of residence. The LHU of Mantova was taken as
reference because, as previously reported,15 after adjust-
ment for age, gender and degree of drug use, it has been
identified as the LHU with the highest prevalence of PA.
After adjustment for age (continuous variable), the odds
ratio (OR) and relative 95% confidence interval (CI) between
the groups were calculated. Statistical analysis was per-
formed using SAS software, version 9.1 (SAS Inc., Cary, NC,
USA). A p value <0.05 was considered to be statistically
significant.
Results
Characteristics and drug prescription profile of the
PA 6e17 year old population
During 2008, 40,528 children and adolescents 6e17 years
old received at least one age-appropriate anti-asthmatic
drug prescription and were therefore identified as PA. This
represents 3.9% of the 6e17 year old population studied
(4.9 and 2.9% of the 6e17 year old boys and girls, respec-
tively). Mean age of PA was 11 and percentage of boys was
64% (Table 1), with a boy/girl ratio of 1.8. Among PA,
occasional users were 10,091 (prevalence 0.96%), low users
were 18,066 (prevalence 1.73%), and high users were
12,371 (prevalence 1.18%).
The population prescription profile showed that 79%
received inhaled corticosteroids (ICS) and 38% received ICS
without any other controller drug. Seventy percent of PA
received short-acting beta2 agonists (18% exclusively). No
differences in these percentages were found between boys
and girls.
Specialist visits
In all, 4900 PA subjects (12%) underwent allergologist or
pneumologist visits and, among these, 2897 subjects had
Table 1 Characteristics of children undergoing spirometry.
Spirometry p
Yes (NZ 12,018) No (28,510) Total (NZ 40,528)
Age (mean SD) 12.4 2.9 10.8 3.4 11.3 3.4 < 0.0001
No. anti-asthma drug
prescriptions
(mean SD)
3.7 3.4 3.2 3.0 3.4 3.1 <0.0001
Male (%) 71.3 61.2 64.3 <0.0001
Hospitalized for asthma (%) 1.3 1.0 1.1 0.005
Spirometry testing in Italian children 1385only one visit (59%), 1243 had two visits (25%), and 15% had
three or more visits during the year considered. The
proportion of PA children with a specialist visit increased
with the degree of anti-asthmatic drug use, from 10% in
occasional users to 20% in high users (ct
2Z 382, p< 0.0001),
and no differences were found between genders (Fig. 1A).
Of the overall PA subjects who underwent a specialist visit,
50% did not undergo spirometry testing during the same
observation period (Fig. 1A).
Spirometry rate of the PA 6e17 year old population
A total of 158,137 children and adolescents underwent at
least one spirometry test during 2008, 12,018 of whom were
identified as potential asthmatics (29.7% of the total PA).
(Table 1)
As shown in Fig. 1B, the proportion of PA with at least one
spirometry test was greater in males than females (32.9 vs.
23.9%; c2Z 361, p< 0.0001). Moreover, this percentage
increased with degree of anti-asthma medication use, from
26.3% in occasional users to 35% in high users (ct
2Z 209,Figure 1 Prevalence of youths performing specialist visit (A) ap< 0.0001). Ninety-three percent of the overall PA subjects
had only one spirometry testing during the period considered
and 7% had two, with no difference between girls and boys.
The prevalence of spirometry testing among the non-
potential asthmatic youths was 14.6%, again with a differ-
ence between genders. Seventy-five percent of theoverall PA
youths undergoing spirometry did not receive any specialist
visit claims during the same observation period (Fig. 1B).
In Fig. 2 the age and gender differences of PA subjects
receiving a spirometry are reported. From age 6e11,
spirometry claims increased in both genders, after which
boys received more spirometry claims than girls. A decrease
for both genders followed after age 13.
Differences among LHUs
The proportion of children with at least one claim for
spirometry differed among LHUs. The proportion ranged
between 20.6% in Sondrio and 39.7% in Lodi.
No statistically significant correlation was found
between the rank distribution at LHU level of percentage ofnd undergoing spirometry test (B). MZmales ; FZ females.
Figure 2 Prevalence of youths, by gender and age, performing at least one spirometry test during 2008.
Table 2 Results of multivariate analysis.
No. OR 95% CI
Gender
Female 507,152 Reference
Male 540,089 2.25 2.22 2.23
LHU
Mantova 41,718 Reference
Sondrio 20,708 1.07 1.02 1.13
Pavia 51,764 1.18 1.13 1.23
Milano 119,188 1.22 1.18 1.27
Brescia 130,074 1.43 1.38 1.48
Varese 93,599 1.45 1.40 1.51
Como 64,079 1.53 1.47 1.59
Vallecamonica 10,420 1.56 1.46 1.56
Milano 3 11,5682 1.64 1.58 1.70
Lodi 25,048 1.67 1.60 1.75
Milano 2 64,947 1.68 1.62 1.75
Bergamo 126,210 1.79 1.73 1.85
Milano 1 108,759 1.83 1.76 1.89
Cremona 37,009 1.86 1.79 1.94
Lecco 38,036 2.01 1.93 2.09
Anti-asthma drug use
No 1,006,713 Reference
Yes
Occasional 10,091 1.70 1.62 1.78
Low 18,066 2.18 2.10 2.25
High 12,371 3.64 3.64 3.95
1386 M. Bianchi et al.PA children with spirometry testing and prevalence of
potential asthmatic patients, hospitalization rate for
asthma or proportion of children with allergologist and/or
pneumologist visits.
Rate of hospitalization among the PA 6e17 year old
population
A total of 449 (1.1%) PA children and adolescents were
hospitalized (Table 1), with statistically significant differ-
ences in rates of occasional, low and high users (0.3, 0.7
and 2.5 respectively). No significant differences were found
in hospitalization rate by gender, but after adjusting for
degree of anti-asthmatic drugs use, high user girls were
more hospitalized than boys (2.5 vs. 2.1).
Multivariate analyses
Table 2 reports the results of logistic regression analysis.
After adjusting for age (in continuous variable), the prob-
ability of undergoing spirometry testing was greater in
males and in high anti-asthmatic users. Moreover, the LHU
of residence was one of the determinants of spirometry,
with OR ranging from 1.07 to 2.01 vs. Mantova, which was
the LHU used as reference.
Discussion
Although periodic assessment of lung function by spirom-
etry is recommended by guidelines,3e5 and it has been
reported that spirometry can be performed in a reproduc-
ibly good quality in children and adolescents,16 our analyses
highlighted that only 30% of asthmatic youths underwent
spirometry testing in an outpatient ambulatory during 2008.
This percentage was slightly higher (35%) in children who
were high users of anti-asthma therapy. Even considering
a longer observation period of 24 months, less than half of
youths (37%) receiving asthma therapy, also received
spirometry testing every one to two years.
Comparing our study results with the very few studies
regarding rates of spirometry among asthmatic children,
the percentage observed in the Lombardy Region (ranging
among LHUs from 22 to 45%) is slightly higher than that
found in a cohort of 2688 asthmatic American children
(23%), enrolled in a managed care organization andfollowed for three years ,11 and slightly lower than that
found in a Canadian population of the same age range
receiving spirometry for asthma diagnosis (38%).12
In the Lombardy Region the likelihood of receiving
spirometry was associated with several factors: age,
gender, setting (LHU) and, as expected, degree of anti-
asthmatic drug use (proxy for severity of asthma). It is
important to note that after adjusting for degree of anti-
asthmatic drug use and age (as a continuous variable), the
chance to undergo spirometry was two-fold greater in boys
than in girls. The gender gap in spirometry testing was
found also in the non PA group (Fig. 1B) and decreased with
increasing severity of asthma but nevertheless remained in
high users (37% in boys vs. 31% in girls). The possibility of
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Yentl’s syndrome.17 Mainly described for adult women and
in cardiology,18,19 the Yentl syndrome has been reported
also for childhood asthma20 in a Swiss study, in which for
any particular asthma-related symptom, significantly more
boys than girls received treatment. Another, or concomi-
tant, explanation could be that boys have worse asthma
control and need more frequent lung function monitoring.
Girls seem to be monitored less frequently than boys, and
to receive occasional anti-asthma therapy more often than
boys, who are, instead, more chronically treated. Guide-
lines distinguish between degree of asthma severity and
asthma control.3 Although it has been reported that in
a population younger than 18, the characteristics of severe
asthma were more present in boys than in girls,21 in adult
populations several studies suggested that females might
have a worse control of asthma symptoms, despite better
pulmonary function.22e25
According to our data, no difference in hospitalization
rates for asthma was found between male and female PA
youths and this did not support the hypothesis of a worse
asthma control in boys than in girls. On the contrary,
a slightly higher risk of hospitalization was found in high
user girls compared with boys (2.5% vs. 2.1%), suggesting
that an inadequate management might be responsible of
hospitalization.Limitations of the study
This study has some limitations. The observation period was
short, and it is possible that the proportion of asthmatic
children with one spirometry testing in a longer period may
be greater. However, an additional analysis of one-third of
the PA subjects here considered, evaluated also during
2007, confirmed the reported finding. The rate of potential
asthmatics with at least one spirometry test in 2007 or 2008
was slightly higher than the rate of spirometry testing in
2008 only (36.6 vs. 29.6%, respectively), and differences
between boys and girls were maintained using the
2007e2008 observation period (39.8 vs. 31.1%, respec-
tively), and the rate of spirometry among the high users in
the 24-month period was 42.1% (34.4% in 2008 only).
Finally, it might be possible that, at the time of specialist
visit, a spirometry testing was performed but the sum of
subjects with spirometry claim and subjects with visit claim
is still only 42% of PA children/adolescents.Conclusion
In conclusion, educational interventions are needed in
order to encourage use of spirometry in primary care
setting and initiative to address deficiencies in test per-
forming and interpretation.26,27 The main finding of this
study is the low spirometry testing rate in girls. Since
females have more severe asthma in adulthood, an accu-
rate, early monitoring of impaired lung function in girls is
an important piece of paediatric asthma management. To
the best of our knowledge, this is the first study that finds
gender differences in the rate of spirometry testing in
a population of asthmatic children.Conflict of interest
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